Tetraphase Pharmaceuticals (United States)
- Research works
- 57 ▼ 17% vs 2013–17
- Citations
- 2.6k 45.2 per fractional work
- Top-10% rate
- 33.3% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: Tetraphase Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Tetraphase Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antimicrobial Resistance, Epidemiology, Antibiotic Pharmacokinetics, Critically Ill Patients and Antibiotics.
- Antibiotic Therapy
- Bacteremia
- Enantioselective Reactions
- Antiretroviral Therapy
- Phenothiazines
- Peptide Synthesis
- Staphylococcus aureus
- MRSA
- Antimicrobial Stewardship
- Public Health
- Topoisomerases
- Infectious Diseases
- Synthesis
- Wastewater Contaminants
- Drug Discovery
- Pharmaceuticals
- Antibiotics
- Antibiotic Pharmacokinetics
- Antimicrobial Resistance
- ESKAPE Pathogens
- Antibiotic Resistance
- Multidrug-Resistant Bacteria
- Epidemiology
- Critically Ill Patients
- Microbial Communities
- Drug Resistance
- Resistance Genes
- Chemotherapy
- Diagnosis
- DNA
- Virulence Factors
- Healthcare-Associated Infections
- Global Health
- Nanoparticles
- Foldamers
- Biological Activities
- Management
- Cystic Fibrosis
- Medicinal Chemistry
- Anticancer Agents
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antibiotic Resistance14▲ 61×6 topics
- ESKAPE Pathogens10▲ 324×1 topic
- Multidrug-Resistant Bacteria10▲ 324×1 topic
- Antimicrobial Resistance10▲ 67×4 topics
- Epidemiology9▲ 3.9×13 topics
- Antibiotic Pharmacokinetics6▲ 240×1 topic
- Critically Ill Patients6▲ 240×1 topic
- Antibiotics4▲ 84×2 topics
- Microbial Communities4▲ 19×2 topics
- Pharmaceuticals4▲ 85×2 topics
- Drug Resistance3▲ 19×3 topics
- Drug Discovery3▲ 15×3 topics
- Resistance Genes3▲ 150×1 topic
- Wastewater Contaminants3▲ 150×1 topic
- Chemotherapy3▲ 7.8×2 topics
- Synthesis3▲ 9.0×5 topics
- Diagnosis3▲ 4.4×5 topics
- Infectious Diseases3▲ 19×2 topics
- DNA2▲ 137×1 topic
- Topoisomerases2▲ 137×1 topic
- Virulence Factors2▲ 23×2 topics
- Public Health2▲ 3.0×2 topics
- Healthcare-Associated Infections2▲ 33×4 topics
- Antimicrobial Stewardship2▲ 133×1 topic
- Global Health2▲ 30×1 topic
- MRSA2▲ 105×1 topic
- Nanoparticles2▲ 2.7×7 topics
- Staphylococcus aureus2▲ 48×1 topic
- Foldamers2▲ 44×1 topic
- Peptide Synthesis2▲ 44×1 topic
- Biological Activities2▲ 17×1 topic
- Phenothiazines2▲ 186×1 topic
- Management2▲ 3.5×2 topics
- Antiretroviral Therapy2▲ 11×3 topics
- Cystic Fibrosis1▲ 29×3 topics
- Enantioselective Reactions1▲ 26×2 topics
- Medicinal Chemistry1▲ 6.0×3 topics
- Bacteremia1▲ 28×2 topics
- Anticancer Agents1▲ 7.3×3 topics
- Antibiotic Therapy1▲ 33×2 topics
Which research topics does Tetraphase Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Pregnancy-related medical research, Injury Epidemiology and Prevention, Antibiotics Pharmacokinetics and Efficacy and Antimicrobial Resistance in Staphylococcus.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pregnancy-related medical research Public Health, Environmental and Occupational Health 0 works
- 2 Injury Epidemiology and Prevention Public Health, Environmental and Occupational Health 0 works
- 3 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 4 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
- 5 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tetraphase Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 17% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Watertown
- Boston Biomedical Research Institute
- Primary Source
- Cambridge Scientific (United States)
- Radiation Monitoring Devices (United States)
- Arsenal Medical (United States)
- Pathfinder International
- New England Research Institutes
- Perkins School for Blind
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.